JP Morgan Chase’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-71,178
| Closed | -$1.05M | – | 7528 |
|
|
2025
Q3 | $1.05M | Sell |
71,178
-8,395
| -11% | -$85.6K | ﹤0.01% | 4555 |
|
|
2025
Q2 | $781K | Buy |
79,573
+4,477
| +6% | +$37.1K | ﹤0.01% | 4527 |
|
|
2025
Q1 | $546K | Sell |
75,096
-233,363
| -76% | -$2.04M | ﹤0.01% | 4706 |
|
|
2024
Q4 | $2.41M | Buy |
308,459
+208,992
| +210% | +$1.72M | ﹤0.01% | 4005 |
|
|
2024
Q3 | $736K | Buy |
99,467
+43,384
| +77% | +$365K | ﹤0.01% | 4668 |
|
|
2024
Q2 | $449K | Sell |
56,083
-4,730
| -8% | -$42.2K | ﹤0.01% | 4745 |
|
|
2024
Q1 | $708K | Sell |
60,813
-138,119
| -69% | -$1.53M | ﹤0.01% | 4569 |
|
|
2023
Q4 | $2.22M | Sell |
198,932
-52,373
| -21% | -$481K | ﹤0.01% | 3767 |
|
|
2023
Q3 | $3.88M | Buy |
251,305
+36,051
| +17% | +$605K | ﹤0.01% | 3029 |
|
|
2023
Q2 | $4.08M | Sell |
215,254
-318,851
| -60% | -$5.6M | ﹤0.01% | 3032 |
|
|
2023
Q1 | $8.13M | Buy |
534,105
+390,176
| +271% | +$5.09M | ﹤0.01% | 2451 |
|
|
2022
Q4 | $1.83M | Sell |
143,929
-79,809
| -36% | -$718K | ﹤0.01% | 3630 |
|
|
2022
Q3 | $1.3M | Buy |
223,738
+91,997
| +70% | +$404K | ﹤0.01% | 3809 |
|
|
2022
Q2 | $424K | Sell |
131,741
-118,011
| -47% | -$356K | ﹤0.01% | 4666 |
|
|
2022
Q1 | $941K | Buy |
249,752
+63,280
| +34% | +$408K | ﹤0.01% | 4317 |
|
|
2021
Q4 | $2.44M | Buy |
186,472
+65,280
| +54% | +$1.03M | ﹤0.01% | 3705 |
|
|
2021
Q3 | $2.37M | Sell |
121,192
-1,975
| -2% | -$36.1K | ﹤0.01% | 3653 |
|
|
2021
Q2 | $2.3M | Sell |
123,167
-92,538
| -43% | -$2.07M | ﹤0.01% | 3695 |
|
|
2021
Q1 | $5.11M | Sell |
215,705
-22,710
| -10% | -$524K | ﹤0.01% | 2957 |
|
|
2020
Q4 | $5.81M | Buy |
238,415
+59,185
| +33% | +$1.51M | ﹤0.01% | 2679 |
|
|
2020
Q3 | $4.47M | Sell |
179,230
-7,324
| -4% | -$232K | ﹤0.01% | 2665 |
|
|
2020
Q2 | $3.72M | Buy |
186,554
+4,484
| +2% | +$109K | ﹤0.01% | 2680 |
|
|
2020
Q1 | $4.6M | Buy |
182,070
+181,112
| +18,905% | +$5.29M | ﹤0.01% | 2325 |
|
|
2019
Q4 | $25K | Buy |
+958
| New | +$26.7K | ﹤0.01% | 5284 |
|
Other funds holding ETNB
JP Morgan Chase's ETNB Position: Q4 2025 in Review
JP Morgan Chase sold out of 89bio (ETNB) in Q4 2025, closing a stake of 71,178 shares — an estimated $1.05M sold.
JP Morgan Chase first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $8.13M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- JP Morgan Chase reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- JP Morgan Chase sold 71,178 89bio shares in Q4 2025, an estimated $1.05M.
- JP Morgan Chase first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
- JP Morgan Chase's 89bio position peaked at $8.13M in Q1 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.